Thanks to Dr Carole Helissey Helissey carole for this great collaboration !
➡️ Neoadjuvant CT + IO in 🫁 cancer.
.
pubmed.ncbi.nlm.nih.gov/38731244/
.

Our fellows presented their work #SSO2024

Gabriela Alejandra Buerba on their work on omitting ALND with positive SLNB post neoadjuvant therapy
📈No difference in DFS or OS for completion ALND vs not
Sunnybrook Health Sciences Centre Frances Wright Society of Surgical Oncology

Fantastic news!!!!!!

Amazingly, my latest MRI brain scan shows no recurrence 10 months since my #glioblastoma presented with a seizure in #Poland . Median time to recurrence is 6 months.

I’m extremely hopeful that the novel #neoadjuvant combination #immunotherapy I’ve had &…

3P Solutions - The first edition of the I.N.N.O.V.A.T.E - Neoadjuvant immunotherapy across cancers
3PSolution Paolo A. Ascierto Christian Blank Liz Burton
oncodaily.com/63471.html

#Cancer #Cancer Research #HealthcareAdvancements #ImmunoTherapy #OncoDaily #Oncology

💊Pembrolizumab in addition to Dabrafenib/Trametinib for BRAFV600E-mutated anaplastic thyroid carcinoma
Thyroid Journal

✅Pembrolizumab added upfront or at progression vs dabra-trame alone
mOS: 17 vs 9 mo, p=0.03
mPFS: 11 vs 4 mo, p=0.04
✅If dabra-trame given as neoadjuvant,…

#Melanoma Great debate starting now #Neoadjuvant Therapy Society of Surgical Oncology #SSO2024 packed room Charlotte Ariyan Alex Van Akkooi Melanoma Research Foundation Melanoma Research Melanoma Institute Australia AnnalsSurgOncology AIM at Melanoma Foundation

Happy to share with you our newest work about an unusual type of breast cancer and the controversy about a topic I am very interested in: Neoadjuvant therapy

authors.elsevier.com/a/1iqoXmiQOtWIj

کیت میدلتون از ابتدایش به سرطان خبر داده و تحت Neoadjuvant chemotherapy قرار گرفته.
چقدر این زن دوست داشتنی و محبوبه.

#DCRJournalClub Reca[ | Dr. Bhutiani on how do you manage liver metastases in a patient with stage IV rectal cancer that has undergone total neoadjuvant therapy and experienced a pathologic complete response at the rectum?

🔴Reasons for not undergoing subsequent pancreatectomy after neoadjuvant treatment in pancreatic cancer
Secondary Analysis of SWOG Cancer Research Network S1505
Journal of the @NCCN

➡️28.4% did not have surgery
✔️progression 10.8%
✔️toxicity during NT 8.8%
✔️Weight loss and hospital’s city size were associated…

Excellent overview of the current state of neoadjuvant systemic therapy in down-staging axillary management and where we are headed in the future by Sarah McLaughlin (No, she will never get a X handle).

Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer

An excellent mini-review👇 ascopubs.org/doi/10.1200/JC…

news.cancerconnect.com/pancreatic-can…

Congratulations to Dr. Murugesan Manoharan, chief of urologic surgery, for presenting at #AUA24 and winning 'Best Poster' for his work 'Neoadjuvant Chemotherapy with Radical Cystectomy in Muscle-Invasive Bladder Cancer: Evaluating the Pathological Response and Survival Outcomes…

Looking forward to #IHPBA2024 #CapeTown 🇿🇦! Meeting up with old and new friends and exciting new evidence RCTs to be discussed! Incl DIPLOMA-2 trial results and newest in #pancreas #liver #biliary #cancer #surgery #robot #laparoscopy #neoadjuvant #pancreatitis

➡️program now…

First of the GI specific sessions starting with Oesophagus. Let's see what's to be said about role of predictive markers, neoadjuvant CRT and surgery when and how? #ESTRO24

🧬ctDNA during neoadjuvant chemotherapy in breast cancer
The Breast Online ESMO - Eur. Oncology

✅Larger decrease in ctDNA levels, pCR⬆️
✅Interval on-treatment ctDNA is predictive for the response
✅Early change of ctDNA (decrease vs increase) is associated with recurrence-free survival…

The NADINA trial of neoadjuvant ipi/nivo vs adjuvant nivo in melanoma is a plenary #ASCO24 . Shorter periods of therapy in responders (neoadjuvant alone) is an important question. Neoadjuvant nivo didn’t work in RCC (PROSPER). PACIFIC2 struggled in lung ascopubs.org/doi/10.1200/JC…

Excited to share the podium to discuss neoadjuvant therapies at #AACR2024 with these superstars ⁦🤩 Duke Univ Dr. Georgia Beasley (melanoma) and Univ of Miami ⁦Jon Trent, MD, PhD⁩ (sarcoma) ⁦MD Anderson Cancer Center⁩ (breast cancer) #endcancer #oncsurgery

📢 News from the ANISC Consensus Conference! 🇮🇹
💻 Held online, 164 #breastcancer specialists from 74 centers debated the evolving role of neoadjuvant chemotherapy in breast cancer treatment. 🎯
Check the results in European Journal of Surgical Oncology
Lucio Fortunato Donatella Santini Breast Cancer Research Updates